GrUVen-I Study |
Change in Manufacture Process of Heberbiovac HB vaccine. |
NEUVITAL V Study |
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 2-4-6 months. |
CENTAURO Study |
Alum Phospate Adjuvated QuimiHib® Vaccine Clinical Study. |
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 6-10-14 weeks. |
Early use of surfacen in the respiratory distress syndrome of the newborn. Phase IV |
Phase I/II clinical trial for the evaluation of vaccine candidate CIGB-230 in patients with chronic renal insufficiency. |
Efficacy of the Glicigen – Viusid in the treatment of external genitals anus wart in children |
Effect and Safety of ior® EPOCIM in patients with Non-Hodking Lymphoma treated with anthracyclines. |
Mebendazole compared with secnidazole-adult giardiasis-Phase III |
Lidoment - pain osteomioarticular - phase IV |
THERESA-3 Study |
EPOCIM in benign prostatic hyperplasia. |
Cicatrix Cream in post surgical scarps and epidermic burn |
Cicatrix Cream in cutaneous striae |
Nimotuzumab- Head and neck cancer |
Effectiveness and safety of ior EPOCIM in anemia in premature infant. |
Effectiveness and Safety of Nimotuzumab for the treatment of patients with glioma tumors |